U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07295301) titled 'Protein Intake Dosage on the Prognosis of Neurocritical Patients' on Dec. 07.
Brief Summary: This study investigates the effect of different early protein supplementation levels (1.0-2.0g/kg/d, divided into three groups) on the prognosis of neurocritical patients, focusing on the 28-day Glasgow Coma Scale (GCS) score improvement rate. Participants will be randomly assigned to receive varying protein doses, and their short-term (28-day mortality, ICU stay, complications) and long-term (90-day mortality, readmission rate) clinical outcomes will also be compared.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Ne...